Ovarian tumor cell detection in peripheral blood progenitor cells harvests by RT-PCR

References

• Kanteti R, Miller K, McCann J, Roitman D, Morelli J, Hurley C et al. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkins lymphoma and Hodgkin s disease: a clinical and molecular analysis. Bone Marrow Transplant 1999; 24: 473–81.
   Google Scholar
• Corsetti MT, Lerma E, Dejana A, Basta P, Ferrara R, Benvenuto F et al. Quantitative competitive reverse transcriptase-polymerase chain reaction for BCR-ABL on Philadelphia-negative leukaphereses allows the selection of low-contaminated peripheral blood progenitor cells for autografting in chronic myelogenous leukemia. Leukemia 1999; 13: 999–1008.
   Google Scholar
• Lopez M, Lemoine FM, Firat H, Fouillard L, Laporte JP, Lesage S et al. Bone marrow versus peripheral blood progenitor cells CD34 selection in patients with non-Hodgkin s lymphomas: different levels of tumor cell reduction. Implications for autografting. Blood 1997; 90: 2830–8.
   Google Scholar
• Corradini P Astolfi M, Cherasco C, Ladetto M, Voena C, Caracciolo D et al. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkins lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. Blood 1997; 89: 724–31.
   Google Scholar
• Vescio RA, Han EJ, Schiller GJ, Lee JC, Wu CH, Cao J et al. Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts. Bone Marrow Transplant 1996; 18: 103–10.
   Google Scholar
• Cooper BW, Moss TJ, Ross aA, Ybanez J, Lazarus HM. Occult tumor contamination of hematopoietic stem-cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer. J Clin Oncol 1998; 16: 3509–17.
   Google Scholar
• Weaver CH, Moss T, Schwartzberg LS, Zhen B, West J, Rhinehart S et al. High-dose chemotherapy in patients with breast cancer: evaluation of infusing peripheral blood stem cells containing occult tumor cells. Bone Marrow Transplant 1998; 21: 1117–24.
   Google Scholar
• Schulze R, Schulze M, Wischnik A, Ehnle S, Doukas K, Behr W et al. Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients. Bone Marrow Transplant 1997; 19: 12238.
   Google Scholar
• Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994; 83: 636–40.
   Google Scholar
• Ross AA, Miller GW, Moss TJ, Kahn DG, Warner NE, Sweet DL et al. Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer. Bone Marrow Transplant 1995; 15: 929–33.
   Google Scholar
• Vannucchi AM, Bosi A, Glinz S, Pacini P, Linari S, Saccar-di R et al. Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA. Br J Haematol 1998; 103: 610–7.
   Google Scholar
• Fischmeister G, Zoubek A, Jugovic D, Witt V, Ladenstein R, Fritsch G et al. Low incidence of molecular evidence for tumour in PBPC harvests from patients with high risk Ewing tumours. Bone Marrow Transplant 1999; 24: 405–9.
   Google Scholar
• Kruger W, Togel F, Kroger N, Rossing S, Gieseking F, Gutensohn K et al. Tumour cell detection in G-CSF mobilised stem cell harvests of patients with breast cancer. Med Oncol 1999; 16: 17–22.
   Google Scholar
• Hildebrandt MO, Blaser F, Beyer J, Siegert W, Mapara MY, Huhn D et al. Detection of tumor cells in peripheral blood samples from patients with germ cell tumors using immunocytochemical and reverse transcriptase-polymerase chain reaction techniques. Bone Marrow Transplant 1998; 22: 771–5.
   Google Scholar
• Hildebrandt M, Rick O, Salama A, Siegert W, Huhn D, Beyer J. Detection of germ-cell tumor cells in peripheral blood progenitor cell harvests: impact on clinical outcome. Clin Cancer Res 2000; 6: 4641–6.
   Google Scholar
• Makino S, Harada M, Akashi K, Taniguchi S, Shibuya T, Inaba S et al. A simplified method for cryopreservation of peripheral blood stem cells at -80 degrees C without ratecontrolled freezing. Bone Marrow Transplant 1991; 8: 23944.
   Google Scholar
• Nakamori S, Kameyama M, Furukawa H, Takeda O, Sugai S, Imaoka S et al. Genetic detection of colorectal cancercells in circulation and lymph nodes. Dis Colon Rectum 1997; 40: S29–36.
   Google Scholar
• Berezowski K, Stastny JF, Kornstein MJ. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 1996; 9: 426–9.
   Google Scholar
• Yanagibashi T, Gorai I, Nakazawa T, Miyagi E, Hirahara F Kitamura H et al. Complexity of expression of the intermediate filaments of six new human ovarian carcinoma cell lines: new expression of cytokeratin 20. Br J Cancer 1997; 76: 829–35.
   Google Scholar